CTEP Branches and Offices
Tables of Possible Side Effects for Commonly-Used Oncology Drugs
Note: The Tables of Possible Side Effects provided below are designed so they may be cut-and-pasted into the “What possible risks can I expect from taking part in this study?” section of the NCI Consent Form Template.
All comments and questions should be directed to NCICTEPComments@mail.nih.gov.
5-Fluorouracil
Abiraterone
Alfa 2 InterFERON 2b
Anastrozole
Arsenic Trioxide
Asparaginase Erwinia chrysanthemi
Bendamustine
Bicalutamide
Bleomycin
Busulfan
Cabazitaxel
Capecitabine
Carboplatin
Carfilzomib
Carmustine
Celecoxib
Cetuximab
Cisplatin
Cladribine
Clofarabine
Cyclophosphamide
Cytarabine
Cytarabine (IT Ara-C)
Dacarbazine
Dactinomycin
Daunorubicin
Dexamethasone
Dexrazoxane
Docetaxel
Doxorubicin
Epirubicin
Erlotinib
Etoposide
Everolimus
Exemestane
Fludarabine
Flutamide
Fulvestrant
Filgrastim
Gemcitabine
Gemtuzumab Ozogamicin
Goserelin
Hydroxyurea
Ibritumomab
Idarubicin
Ifosfamide
Imatinib
Irinotecan
Isotretinoin
Letrozole
Leucovorin
Leuprolide
Liposomal doxorubicin
Lomustine
Melphalan
Mercaptopurine
Mesna
Metformin
Methotrexate (ITMTX)
Methotrexate (not ITMTX)
Methylprednisolone
Mitomycin
Mitotane
Mitoxantrone
Nelarabine
Nilotinib
Nilutamide
Octreotide
Ofatumumab
Oxaliplatin
Paclitaxel
Paclitaxel protein-bound particles
Panitumumab
Pegaspargase or Calaspargase
Pegfilgrastim
Pemetrexed
Pentostatin
Ponatinib
Prednisone
Procarbazine
Rituximab
Sargramostim
Sirolimus
Streptozocin
Tacrolimus
Tamoxifen
Temozolomide
Thioguanine
Thiotepa
Topotecan
Trastuzumab
Tretinoin
Triptorelin
Vandetanib
Vinblastine
Vincristine
Vinorelbine